Clinical Trials

ID: 17-06-327-01
TITLE: Advanced or Metastatic Renal Cell Carcinoma (RCC)
SUMMARY:

People with Renal Cell Carcinoma are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a least 18 years of age
  • Have confirmed diagnosis of renal cell carcinoma with a clear-cell component
  • Have received at least two prior lines of systemic therapy, including at least one VEGFR-targeting TKI (e.g., sunitinib, sorafenib, pazopanib,) and cabozantinib or nivolumab

You may not participate in this study if you:

  • Have had prior treatment with everolimus, temsirolimus or CB-839
  • Have had major surgery within the past 28 days
  • Have known active infection with HIV, Hepatitis B or Hepatitis C virus
  • Are pregnant or breastfeeding

Prena Etchen, Study Coordinator
1521 Jarrett Place
Bronx, NY 10461
Phone: (718) 379-6869
Email: pzagreda@montefiore.org

-